
John S. Kenyon
Examiner (ID: 1783, Phone: (571)270-1567 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1622 |
| Total Applications | 1238 |
| Issued Applications | 858 |
| Pending Applications | 135 |
| Abandoned Applications | 275 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18329173
[patent_doc_number] => 11634401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Process-scale synthesis of urolithin A
[patent_app_type] => utility
[patent_app_number] => 17/141472
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8041
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141472 | Process-scale synthesis of urolithin A | Jan 4, 2021 | Issued |
Array
(
[id] => 18287249
[patent_doc_number] => 20230102721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 17/787389
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787389 | Organic electron transfer mediator and device comprising same | Dec 27, 2020 | Issued |
Array
(
[id] => 18181796
[patent_doc_number] => 20230042525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/786647
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786647 | JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION | Dec 21, 2020 | Abandoned |
Array
(
[id] => 17687626
[patent_doc_number] => 20220194918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => PLEUROMULIN LIPOIC ACID ESTER WITH ANTIBACTERIAL ACTIVITY AND A METHOD OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/128103
[patent_app_country] => US
[patent_app_date] => 2020-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128103
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128103 | Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same | Dec 18, 2020 | Issued |
Array
(
[id] => 18158337
[patent_doc_number] => 20230024928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => CAI NANOEMULSIONS
[patent_app_type] => utility
[patent_app_number] => 17/785842
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785842 | CAI nanoemulsions | Dec 17, 2020 | Issued |
Array
(
[id] => 18817403
[patent_doc_number] => 20230391743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => METHOD OF PREPARING ORGANOSULFUR COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/034025
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034025 | Method of preparing organosulfur compound | Dec 17, 2020 | Issued |
Array
(
[id] => 16946597
[patent_doc_number] => 20210205288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/125164
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125164 | Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome | Dec 16, 2020 | Issued |
Array
(
[id] => 16777922
[patent_doc_number] => 20210114999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => TARGETING STAT SUMOYLATION TO ENHANCE IMMUNE RESPONSES
[patent_app_type] => utility
[patent_app_number] => 17/125900
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125900 | Targeting STAT sumoylation to enhance immune responses | Dec 16, 2020 | Issued |
Array
(
[id] => 18280613
[patent_doc_number] => 20230096085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/795670
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795670 | FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR | Dec 15, 2020 | Pending |
Array
(
[id] => 18283949
[patent_doc_number] => 20230099421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS
[patent_app_type] => utility
[patent_app_number] => 17/757653
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757653 | A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS | Dec 14, 2020 | Pending |
Array
(
[id] => 18181059
[patent_doc_number] => 20230041788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => OPHTHALMIC COMPOSITIONS COMPRISING D2O
[patent_app_type] => utility
[patent_app_number] => 17/784841
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -97
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784841 | OPHTHALMIC COMPOSITIONS COMPRISING D2O | Dec 14, 2020 | Pending |
Array
(
[id] => 18964143
[patent_doc_number] => 11897893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Molecular containers and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/121241
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 51
[patent_no_of_words] => 14277
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17121241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/121241 | Molecular containers and methods of making and using same | Dec 13, 2020 | Issued |
Array
(
[id] => 18306478
[patent_doc_number] => 20230110378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => MONOBACTAM COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/784971
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 589
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784971 | MONOBACTAM COMPOUND AND USE THEREOF | Dec 10, 2020 | Abandoned |
Array
(
[id] => 18194010
[patent_doc_number] => 20230047529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX
[patent_app_type] => utility
[patent_app_number] => 17/784368
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 553
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784368 | Method for synthesizing zirconium complex | Dec 7, 2020 | Issued |
Array
(
[id] => 16777917
[patent_doc_number] => 20210114994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Methods for the synthesis of activated ethylfumarates and their use as intermediates
[patent_app_type] => utility
[patent_app_number] => 17/113540
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113540 | Methods for the synthesis of activated ethylfumarates and their use as intermediates | Dec 6, 2020 | Issued |
Array
(
[id] => 17412018
[patent_doc_number] => 20220046922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => LIQUID PESTICIDAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/109400
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109400 | LIQUID PESTICIDAL COMPOSITION | Dec 1, 2020 | Abandoned |
Array
(
[id] => 18109454
[patent_doc_number] => 20230002334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => TRPM8 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/777910
[patent_app_country] => US
[patent_app_date] => 2020-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777910 | TRPM8 MODULATORS | Nov 25, 2020 | Pending |
Array
(
[id] => 18359607
[patent_doc_number] => 20230141198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PYRAZOLOMORPHINAN DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/777536
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777536 | PYRAZOLOMORPHINAN DERIVATIVE | Nov 19, 2020 | Abandoned |
Array
(
[id] => 18180913
[patent_doc_number] => 20230041642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => Aggregation Inhibitory Agent and Medical Composition and Medical Device Including Same
[patent_app_type] => utility
[patent_app_number] => 17/785612
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785612
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785612 | Aggregation Inhibitory Agent and Medical Composition and Medical Device Including Same | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18336739
[patent_doc_number] => 20230128688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => DIRECTED CONJUGATION TECHNOLOGIES
[patent_app_type] => utility
[patent_app_number] => 17/769924
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 110752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769924 | DIRECTED CONJUGATION TECHNOLOGIES | Nov 17, 2020 | Pending |